NCT03067194View on ClinicalTrials.gov

The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

December 27, 2016

Primary Completion Date

July 10, 2017

Study Completion Date

November 20, 2018

Conditions
Osteoarthritis Hand
Interventions
DRUG

Celecoxib 100 MG

Celecoxib 100mg, Oral, BID(twice per day), During 6 weeks

DRUG

Celecoxib 200mg

Celecoxib 200mg, Oral, QD(once daily), During 6 weeks

Trial Locations (1)

Unknown

Soon Chun Hyang University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY